๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers Clinical trials Qionghai
Clinical trial register · China

Clinical Trials in Qionghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Qionghai

8 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
ZVS101e in Patients With Bietti's Crystalline Dystrophy
NCT07653971Bietti's Crystalline Dystrophy, Bietti Crystalline Corneoretinal Dystrophy
Chigenovo Co., Ltd
Not applicable
300
Qionghai
2026-09-30
Not yet open
KSD-101 in Patients With EBV-associated Hematological Malignancies
NCT07525024EBV Associated Lymphoid Neoplasms
Ruijin Hospital
Observational
80
Qionghai
2026-04
Recruiting
REGEND001 Autologous Basal Layer Stem Cell Transplantation for Interstitial Lung Disease (ILD): A Translational Application Study
NCT06998706Interstitial Lung Disease (ILD)
Ruijin Hospital
Phase 1
10
Qionghai, Shanghai
2025-06-19
Recruiting
REGEND001 Autologous Basal Layer Stem Cell Transplantation for Bronchiectasis: A Translational Application Study
NCT06987214Bronchiectasis Adult
Ruijin Hospital
Phase 1
10
Qionghai, Shanghai
2025-06-18
Recruiting
REGEND001 Autologous Basal Layer Stem Cell Transplantation for Chronic Obstructive Pulmonary Disease (COPD): A Translational Application Study
NCT06946953Chronic Obstructive Pulmonary Disease (COPD)
Ruijin Hospital
Phase 1/2
20
Qionghai, Shanghai
2025-03-23
Recruiting
Disitamab Vedotin (RC48) in Hormone Receptor Positive, HER2-low Metastatic Breast Cancer (the Rosy Trial)
NCT05904964HR Positive/HER2 Low Expression Metastatic Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Phase 3
288
Guangzhou, Shantou, Qionghai
2023-07-01
Recruiting
Personalized Tumor Vaccines and Pabolizumab in Patients With Advanced Pancreatic Cancer
NCT05916261Advanced Pancreatic Cancer
Ruijin Hospital
Phase EARLY_PHASE1
54
Qionghai
2023-04-26
Rows per page Showing 1–8 of 8
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/qionghai

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 8 of those studies with a site in Qionghai.

How many clinical trials are recruiting in Qionghai?

5 of the 8 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 2 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Qionghai), 8 studies
PhaseStudiesRecruitingShare
Not applicable2025%
Phase 12225%
Observational1012.5%
Phase 1/21112.5%
Phase 31112.5%
Phase EARLY_PHASE11112.5%

Most active sponsors

Lead sponsors with the most studies (Qionghai)
Lead sponsorStudiesRecruiting
Ruijin Hospital54
Chigenovo Co., Ltd10
Servier (Tianjin) Pharmaceutical Co. LTD.10
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.